Literature DB >> 28104386

Haemagglutinin and neuraminidase sequencing delineate nosocomial influenza outbreaks with accuracy equivalent to whole genome sequencing.

Rebecca Houghton1, Joanna Ellis2, Monica Galiano2, Tristan W Clark3, Sarah Wyllie4.   

Abstract

OBJECTIVES: We describe haemagglutinin (HA) and neuraminidase (NA) sequencing in an apparent cross-site influenza A(H1N1) outbreak in renal transplant and haemodialysis patients, confirmed with whole genome sequencing (WGS).
METHODS: Isolates were sequenced from influenza positive individuals. Phylogenetic trees were constructed using HA and NA sequencing and subsequently WGS. Sequence data was analysed to determine genetic relatedness of viruses obtained from inpatient and outpatient cohorts and compared with epidemiological outbreak information.
RESULTS: There were 6 patient cases of influenza in the inpatient renal ward cohort (associated with 3 deaths) and 9 patient cases in the outpatient haemodialysis unit cohort (no deaths). WGS confirmed clustered transmission of two genetically different influenza A(H1N1)pdm09 strains initially identified by analysis of HA and NA genes. WGS took longer, and in this case was not required to determine whether or not the two seemingly linked outbreaks were related.
CONCLUSION: Rapid sequencing of HA and NA genes may be sufficient to aid early influenza outbreak investigation making it appealing for future outbreak investigation. However, as next generation sequencing becomes cheaper and more widely available and bioinformatics software is now freely accessible next generation whole genome analysis may increasingly become a valuable tool for real-time Influenza outbreak investigation. Crown
Copyright © 2017. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Genomics; Healthcare associated infection; Influenza; Outbreak; Renal transplantation

Mesh:

Substances:

Year:  2017        PMID: 28104386     DOI: 10.1016/j.jinf.2016.12.015

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  5 in total

1.  Use of Genome Sequencing to Define Institutional Influenza Outbreaks, Toronto, Ontario, Canada, 2014-15.

Authors:  Derek R MacFadden; Allison McGeer; Taryn Athey; Stephen Perusini; Romy Olsha; Aimin Li; AliReza Eshaghi; Jonathan B Gubbay; William P Hanage
Journal:  Emerg Infect Dis       Date:  2018-03       Impact factor: 6.883

2.  Identification of influenza urban transmission patterns by geographical, epidemiological and whole genome sequencing data: protocol for an observational study.

Authors:  Tanja Stadler; Rita Schneider-Sliwa; Adrian Egli; Claudia Saalfrank; Nina Goldman; Myrta Brunner; Yvonne Hollenstein; Thomas Vogel; Noémie Augustin; Daniel Wüthrich; Helena M B Seth-Smith; Elisa Roth; Mohammedyaseen Syedbasha; Nicola F Mueller; Dominik Vogt; Jan Bauer; Nadezhda Amar-Sliwa; Dominik M Meinel; Olivier Dubuis; Michael Naegele; Sarah Tschudin-Sutter; Andreas Buser; Christian H Nickel; Andreas Zeller; Nicole Ritz; Manuel Battegay
Journal:  BMJ Open       Date:  2019-08-20       Impact factor: 2.692

3.  Poor transmission of seasonal cold viruses in a British Antarctic Survey base.

Authors:  Tom Everett; Jenny Douglas; Shoshanna May; Simon Horne; Peter Marquis; Richard Cunningham; Julian W Tang
Journal:  J Infect       Date:  2019-03-14       Impact factor: 6.072

4.  Whole-genome Sequencing Provides Data for Stratifying Infection Prevention and Control Management of Nosocomial Influenza A.

Authors:  Sunando Roy; John Hartley; Helen Dunn; Rachel Williams; Charlotte A Williams; Judith Breuer
Journal:  Clin Infect Dis       Date:  2019-10-30       Impact factor: 9.079

5.  Nosocomial transmission of influenza: A retrospective cross-sectional study using next generation sequencing at a hospital in England (2012-2014).

Authors:  Ruth M Blackburn; Dan Frampton; Catherine M Smith; Ellen B Fragaszy; Simon J Watson; R Bridget Ferns; Špela Binter; Pietro G Coen; Paul Grant; Laura J Shallcross; Zisis Kozlakidis; Deenan Pillay; Paul Kellam; Stéphane Hué; Eleni Nastouli; Andrew C Hayward
Journal:  Influenza Other Respir Viruses       Date:  2019-09-19       Impact factor: 4.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.